BridgeMD
New treatment option for Breast Cancer Survivor
Official title tDCS Intervention in Breast Cancer Survivors With and Without Obesity Reporting Cognitive Impairment
ClinicalTrials.gov ID: NCT07112521
What this study is testing
- What it's testing
- The goal of this intervention is to investigate whether transcranial Direct Current Stimulation (tDCS) can alleviate Cancer-Related Cognitive Impairment (CRCI) in breast cancer survivors, as measured by changes in brain structures and cognitive performance. To assess the efficacy of tDCS, the investigators will compare outcomes between participants receiving active stimulation and those receiving sham stimulation (a placebo condition where participants believe they are receiving stimulation, but are not).
- You might receive a placebo (an inactive treatment) instead of the study drug. You may not know which one you got.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older, women only
You may be able to join if
- Female
- Over 18 years old
- Diagnosed with primary adult-onset breast cancer within the last 5 years
- Completed all active cancer treatments at least 3 months prior to study participation
- Capable of fulfilling study requirements, including having internet access.
You likely can't join if
- Have received primary cancer treatment (chemotherapy, radiotherapy, immunotherapy, or surgery) within the last 3 months
- Have a history of childhood-onset cancer
- Present with acute eczema on the scalp
- Diagnosed with dementia, Alzheimer's disease, multiple sclerosis, or - Parkinson's disease
- Have experienced unconsciousness for more than five minutes due to a head/brain injury within the last 10 years
- Have a history of stroke or transient ischemic attack
See the full eligibility criteria
- Female
- Over 18 years old
- Diagnosed with primary adult-onset breast cancer within the last 5 years
- Completed all active cancer treatments at least 3 months prior to study participation
- Capable of fulfilling study requirements, including having internet access.
- Fluent in either Finnish or English
- Have normal or corrected vision and hearing
- Right-handed (based on the Edinburgh Handedness Inventory score; Oldfield, 1971)
- Have received primary cancer treatment (chemotherapy, radiotherapy, immunotherapy, or surgery) within the last 3 months
- Have a history of childhood-onset cancer
- Present with acute eczema on the scalp
- Diagnosed with dementia, Alzheimer's disease, multiple sclerosis, or - Parkinson's disease
- Have experienced unconsciousness for more than five minutes due to a head/brain injury within the last 10 years
- Have a history of stroke or transient ischemic attack
- Suffer from claustrophobia
- Are pregnant or breastfeeding
- Have any of the following medical implants or devices: cardiac implantable electronic devices, metallic intraocular foreign bodies, neurostimulation systems, cochlear/ear implants, drug infusion pumps, catheters with...
- Weight exceeding 250 kg (the MRI table weight limit) or they are unable to fit within the 70 cm diameter bore of the MRI machine
The study team makes the final eligibility decision.
Where it's taking place
- Helsinki, Uusimaa, Finland
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling female, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Helsinki, Uusimaa, Finland. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.